Sponsor:
OnKure, Inc.
Code:
NCT06239467
Conditions
Advanced Cancer
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OKI-219
Fulvestrant
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by OnKure, Inc. on 2025-03-06.